Replimune Group, Inc. (NASDAQ:REPL) Receives $51.67 Average Price Target from Brokerages

Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Rating) have received an average recommendation of “Buy” from the six research firms that are currently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock […]

Related Keywords

Piper Sandler ,News Ratings For Replimune Group Daily ,Replimune Group Inc ,Nasdaq ,Vanguard Group Inc ,Pricet Rowe Associates Inc ,Ef Hutton Acquisition Co ,Replimune Group ,T Rowe Price Investment Management Inc ,Replimune Group Company Profile ,Blackrock Inc ,Analyst Recommendations For Replimune Group ,Replimune Group Trading Down ,Get Rating ,Street Corp ,Price Investment Management ,Rowe Price Investment Management ,Group Trading Down ,Replimune Group Daily ,Nasdaq Repl ,Trepl ,Medical ,Ratings ,Consensus ,